Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer. https://t.co/mdVaBI9xTD
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https://t.co/FNhkgTHqVW ACE inhibitorがアンスラサイクリンの心筋障害を予防できるってことよりも、こんなに心毒性出るってことの方がびっくりした…
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https://t.co/OKTGFL5bVD
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
In patients with HER2-positive breast Ca on trastuzumab x 12 months & prior anthracycline use, lisinopril or carvedilol at 10 mg/day improved cardiotoxicity-free survival at 2 years vs. placebo, with less interruption of therapy. No difference in non-
“Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Pts With Breast #Cancer”; this is likely germane to other cancers w/ #anthracycline use. Need much more tertiary prevention studies like this https://t.co/tQfCqzzmy5
New2Trip: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients w/ Breast Cancer https://t.co/BBjBfu9alp
New2Trip: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients w/ Breast Cancer https://t.co/BBjBfuqLcX
New2Trip: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients w/ Breast Cancer https://t.co/BBjBfu9alp
乳がん患者におけるトラスツマブの心毒性はリシノプリルやカルベジロール併用で少なくなるかもしれない。 Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer. - PubMed - NCBI https://t.co/GW1CpnZwCf
A novel study--lisinopril and bisoprolol reduced the risk of cardiotoxicity in HER2+ breast CA patients treated with trastuzumab and anthracyclines: https://t.co/eOIqk3jR7v @JACCJournals https://t.co/zEFfZU9ose
In patients with HER2-positive breast cancer treated with trastuzumab, both lisinopril and carvedilol prevented cardiotoxicity in patients receiving anthracyclines. https://t.co/HJBIzXclNu
RT @DralexGva: Sometimes little things can make a big difference. https://t.co/ypayaodY3k
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
Sometimes little things can make a big difference.
RT @dokter_internis: ACE inhibitors or beta blockers can preserve cardiac function and avoid chemotherapy disruption in HER2-positive breas…
RT @dokter_internis: ACE inhibitors or beta blockers can preserve cardiac function and avoid chemotherapy disruption in HER2-positive breas…
RT @dokter_internis: ACE inhibitors or beta blockers can preserve cardiac function and avoid chemotherapy disruption in HER2-positive breas…
RT @dokter_internis: ACE inhibitors or beta blockers can preserve cardiac function and avoid chemotherapy disruption in HER2-positive breas…
RT @DocBanks84: #CardioOncology Community what do you think about the cardiotoxicity rates and definition in this paper? Ace-I and beta blo…
RT @DocBanks84: #CardioOncology Community what do you think about the cardiotoxicity rates and definition in this paper? Ace-I and beta blo…
RT @DocBanks84: #CardioOncology Community what do you think about the cardiotoxicity rates and definition in this paper? Ace-I and beta blo…
RT @DocBanks84: #CardioOncology Community what do you think about the cardiotoxicity rates and definition in this paper? Ace-I and beta blo…
RT @manyooa: @UTHSC_Medicine @uthsc @ACCinTouch Nice study showing how Lisinopril and Carvedilol can minimize interruptions of transtuzumab…
@UTHSC_Medicine @uthsc @ACCinTouch Nice study showing how Lisinopril and Carvedilol can minimize interruptions of transtuzumab + prevent cardiotoxicity in HER2-positive breast cancer pts receiving anthracyclines. https://t.co/uYYyEtHkQn
RT @DocBanks84: #CardioOncology Community what do you think about the cardiotoxicity rates and definition in this paper? Ace-I and beta blo…
#CardioOncology Community what do you think about the cardiotoxicity rates and definition in this paper? Ace-I and beta blocker in all bc patients undergoing trastuzumab and AC? @PrevCardioOnc @GiselleSA_MDPhD @avirupguha @drbrowncares @AnaBaracCardio htt
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
ついでに #CardioJapan
Both ACE-I and bb prevented #cardio #toxicity in patients w HER2 breast-c. #CardioTwitter https://t.co/AoCl6Wndga
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @ATRIUMRx: Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthr…
RT @ATRIUMRx: Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthr…
RT @ATRIUMRx: Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthr…
RT @ATRIUMRx: Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthr…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @ATRIUMRx: Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthr…
RT @ATRIUMRx: Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthr…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
Lisinopril and carvedilol prevented cardiotoxicity in patients with HER2+ breast cancer treated with trastuzumab and an anthracycline @JACCJournals https://t.co/38J5QpabOu https://t.co/x3RJ2aiUUj
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
Look @UofGlasgow professor John MC Murray 1 year after really good discuss in glasgow pub more evidencie Regards from México https://t.co/wEOSOdqV65
Great news for #cardioncology
Great tweet @vass_vassiliou 🙏
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @MattH_MD: Interesting article... Will it change your management? Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzum…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @UmutKocabasMD: HER2+ meme kanseri olan ve transtuzumab + antrasiklin tedavisi gören kadınlarda gerek lisinopril, gerek ise karvedilolün…
Interesting article... Will it change your management? Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https://t.co/rN9AEgB6Nq
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @HeartOTXHeartMD: In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardioto…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
In patients with HER2-positive #breastcancer treated w #trastuzumab, both #lisinopril & #carvedilol prevented cardiotoxicity in pts receiving anthracyclines. For such pts, lisinopril or carvedilol should be considered to minimize interruptions of trast
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @clara_clarais: JACC: como prevenir la cardiotoxicidad en CA de mama, miren los números!!! Cifras alarmantes de toxicidad Randomized T…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @JavierdeJuan1: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer -…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
RT @vass_vassiliou: Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/…
Patients receiving #herceptin and #anthracyclines did better with prophylactic beta blockers and ACE I... https://t.co/8aQZwK8O5w @JACCJournals Further justification to pre-treat everyone on this combination. #breastcancer #cardiooncology #epeeps #cardioed
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @clara_clarais: JACC: como prevenir la cardiotoxicidad en CA de mama, miren los números!!! Cifras alarmantes de toxicidad Randomized T…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…